MARKET

NTBL

NTBL

Notable Labs
NASDAQ
3.790
+0.050
+1.33%
Closed 19:54 11/30 EST
OPEN
3.740
PREV CLOSE
3.740
HIGH
3.790
LOW
3.500
VOLUME
20.27K
TURNOVER
0
52 WEEK HIGH
11.20
52 WEEK LOW
2.250
MARKET CAP
34.11M
P/E (TTM)
-1.0748
1D
5D
1M
3M
1Y
5Y
Notable Labs: [Amend]Current report
Press release · 1d ago
Weekly Report: what happened at NTBL last week (1120-1124)?
Weekly Report · 4d ago
Keay Nakae’s Buy Rating on Notable Labs: Predictive Precision Medicine Platform and Financial Stability as Key Factors
TipRanks · 11/20 13:19
Weekly Report: what happened at NTBL last week (1113-1117)?
Weekly Report · 11/20 10:31
Analysts Are Bullish on These Healthcare Stocks: Notable Labs (NTBL), Karuna Therapeutics (KRTX)
TipRanks · 11/17 05:40
Notable Labs: Current report
Press release · 11/15 09:01
Notable Labs: Quarterly report
Press release · 11/15 01:03
Notable Labs Announces Filing Of Form 10-Q For Q3 2023; As Of October 31, 2023, The Post-Merger Company, Notable Labs, Ltd, Had Cash And Cash Equivalents Of $14.3M
Notable labs, ltd. Is a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients. Notable closed the previously announced merger with vbl therapeutics in october 2023. The form 10-q contains financial results for the third quarter and nine months ended september 30, 2023 of pre-merger vbl.
Benzinga · 11/14 22:17
More
About NTBL
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.

Webull offers Notable Labs Ltd stock information, including NASDAQ: NTBL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTBL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTBL stock methods without spending real money on the virtual paper trading platform.